Skip to search formSkip to main contentSkip to account menu

1 ML secukinumab 150 MG/ML Auto-Injector [Cosentyx]

Known as: Cosentyx 150 MG in 1 ML Auto-Injector, Cosentyx 150 MG per 1 ML Auto-Injector, 1 ML Cosentyx 150 MG/ML Auto-Injector 
National Institutes of Health

Related topics

Related topics

12 relations

Broader (2)

1 ML secukinumab 150 MG/ML Auto-InjectorCosentyx Injectable Product
1 ML secukinumab 150 MG/ML Prefilled Syringe [Cosentyx]Auto-InjectorCosentyxHISTIDINE MONOHYDROCHLORIDE MONOHYDRATE

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Traitements, nouvelles thérapies et prise en charge du psoriasis à l’officine
Le psoriasis est une maladie chronique inflammatoire de la peau affectant 2 a 3 % de la population en France. Il peut alterer… 
Review
2015
Review
2015
Secukinumab: A Review in Moderate to Severe Plaque Psoriasis
Secukinumab (Cosentyx™) is a fully human monoclonal immunoglobulin G1κ antibody targeting human interleukin-17A, an important… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)